Listed

Benchmark Electronics Inc: Form 10-Q for the period ended Sep 30, 2022

Filed with the SEC on Nov 4, 2022 and accepted by EDGAR at Nov 4, 2022, 20:27 ET.

Share

Management's discussion and analysis

As filed, 47,123 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The financial information and the discussion below should be read in conjunction with other information, including the condensed consolidated financial statements and Notes thereto in Part I, Item 1 of this quarterly report on Form 10-Q for the quarterly period ended September 30, 2022 (this Report), consolidated financial statements appearing in the Company’s annual report on Form 10-K for the year ended December 31, 2021 (the Form 10-K), and Part I, Item 1A, Risk Factors of the Form 10-K. In this Report, references to Benchmark, the Company or use of the words “we”, “our” and “us” include Benchmark’s subsidiaries unless otherwise noted.

This Report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are identified as any statement that does not relate strictly to historical or current facts and may include words such as “anticipate,” “believe,” “intend,” “plan,” “project,” “forecast,” “strategy,” “position,” “continue,” “estimate,” “expect,” “may,” “will,” “could,” “predict,” and similar expressions of the negative or other variations thereof. In particular, statements, express or implied, concerning the estimated financial impact of the COVID-19 pandemic, the Company’s outlook and guidance for fourth quarter 2022 results, future operating results or margins, the ability to generate sales and income or cash flow, expected revenue mix, the Company’s business strategy and strategic initiatives, the Company’s repurchases of shares of its common stock, the Company’s expectations regarding restructuring charges and amortization of intangibles, and the Company’s intentions concerning the payment of dividends, among others, are forward-looking statements. Although the Company believes these statements are based on and derived from reasonable assumptions, they involve risks, uncertainties and assumptions that are beyond the Company’s ability to control or predict, relating to operations, markets and the business environment generally, including those discussed under Part I, Item 1A of the Form 10-K, and in any of the Company’s subsequent reports filed with the Securities and Exchange Commission. In particular, these statements also depend on the duration, severity and evolution of the COVID-19 pandemic and related risks, including the emergence and severity of its variants, the availability of vaccines and potential hesitancy to utilize them, government and other third-party responses to the crisis and the consequences for the global economy, the Company’s business and the businesses of its suppliers and customers. Events relating to the possibility of customer demand fluctuations, supply chain constraints, inflationary pressures, the effects of foreign currency fluctuations, or the ability to utilize the Company’s manufacturing facilities at sufficient levels to cover its fixed operating costs, may have resulting impacts on the Company’s business, financial condition, results of operations, and the Company’s ability (or inability) to execute on its plans. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes, including the future results of our operations, may vary materially from those indicated. Undue reliance should not be placed on any forward-looking statements. Forward-looking statements are not guarantees of performance. All forward-looking statements included in this document are based upon information available to the Company as of the date of this document, and the Company assumes no obligation to update.

OVERVIEW

We are a worldwide provider of advanced manufacturing services (both electronic manufacturing services (EMS) and precision technology services), which includes design and engineering services and technology solutions.

From initial product concept to volume production, including direct order fulfillment and aftermarket services, Benchmark has been providing integrated services and solutions to original equipment manufacturers (OEMs) since 1979. Today, Benchmark proudly serves the following industries: aerospace and defense (A&D), medical technologies, complex industrials, semiconductor capital equipment (Semi-Cap), next-generation telecommunications and advanced computing.

Our customer engagement focuses on three principal areas:

  • Manufacturing Services, which include printed circuit board assemblies (PCBAs) using both traditional surface mount technologies and microelectronics, subsystem assembly, system build and integration. System builds and integration often involve building a finished assembly that includes PCBAs, complex subsystem assemblies, mechatronics, displays, optics, and other components. These final products may be configured to order and delivered directly to the end-customer across all the industries we serve. Manufacturing services also includes precision technology services comprised of precision machining, advanced metal joining, assembly and functional testing primarily for the Semi-Cap market (serving semiconductor capital equipment customers) and A&D market.
  • Design & Engineering Services, which include design for manufacturability, design optimization for our factory processes and supply chain, and test development, concurrent and sustaining engineering, turnkey product design and regulatory services. Our engineering services may be for systems, sub-systems, printed circuit boards and assemblies, and components. We have the flexibility and capability to engage anywhere in the customers design process flow. We provide

these services across all the industries we serve, but focus primarily in regulated industries such as medical, complex industrials, A&D, and Semi-Cap.

  • Technology Solutions, which involve developing a library of building blocks or reference designs primarily in defense solutions, surveillance systems, millimeter wave (mmWave) radio frequency (RF) subsystems, and front-end managed connected data collection systems. We often partner with our customers to merge these solutions utilizing our engineering services to provide turnkey product development from requirements through the launch to volume production into our factories. Our building blocks can be utilized across a variety of industries but we have significant focus and capabilities in the A&D and the complex industrials markets. We have also developed differentiated capabilities in RF and high-speed design for both components and substrates. The need to reduce size, weight, and power (SWaP) to accommodate high frequency electronics communications is important to customers in the A&D, medical and next-generation telecommunications markets.

Our core strength lies in our ability to partner with our customers to provide concept-to-production solutions in support of our customers through a tightly integrated and seamless set of design, test, manufacturing, supply chain and support services. The integration of these services along with our global manufacturing presence increases our ability to respond to our customers’ needs by providing accelerated time-to-market and time-to-volume production of high-quality products – especially for complex products with lower volume and higher mix in regulated markets with higher reliability requirements. These capabilities enable us to build strong strategic relationships with our customers and to become an integral part of their business.

We believe our primary competitive advantage is our ability to engage with our customers at any point in their concept to production process by providing our leading edge technical capabilities in engineering services (including product design in which we can take a product idea from concept to design to volume manufacturing), technology solutions (especially high frequency RF solutions and microelectronics), and manufacturing services (including electronics and complex precision machining capabilities) provided by highly skilled personnel. We also have diversified end market and regulated market experience in our targeted higher-value markets. To support customers in these markets, we have invested in strategic global supply chain design and execution.

In addition, we believe that a strong focus on human capital through the talent we hire and retain is critical to maintaining our competitiveness. We are driving a customer-centric organization with a high degree of accountability and ownership to develop processes necessary to exceed customer expectations and deliver financial performance aligned to our goals. Through our employee feedback process, we solicit and act upon information to improve our Company and better support our customers and business processes in the future. We have taken steps to attract the best leaders and are accelerating our efforts to increase our diversity and inclusion in our employee and management ranks as we seek to develop an innovative and forward-thinking workforce for the future.

Our customers often face challenges in designing supply chains, demand planning, procuring materials and managing their inventories efficiently due to fluctuations in their customer demand, product design changes, short product life cycles and component price fluctuations.

We employ enterprise resource planning (ERP) systems and lean manufacturing principles to manage procurement and manufacturing processes in an efficient and cost-effective manner so that, where possible, components arrive on a just-in-time, as-and-when-needed basis. Because we are a significant purchaser of electronic components and other raw materials, we are generally able to capitalize on the economies of scale associated with our relationships with suppliers to negotiate price discounts, obtain components and other raw materials that are in short supply, and return excess components. Utilizing our agility and expertise in supply chain management and our relationships with suppliers across the supply chain, we strive to help reduce our customers’ cost of goods sold and inventory exposure. However, due to the COVID pandemic, as well as global labor and supply disruptions, we continue to see component supply chain constraints across all commodity categories that are constraining our ability to produce the full demand forecasts we are receiving from customers.

We recognize manufacturing services revenue as the customer takes control of the manufactured products built to customer specifications. We also generate revenue from our design, development and engineering services, in addition to the sale of other inventory.

Revenue is measured based on the consideration specified in a contract with a customer. Under the majority of our manufacturing contracts with customers, the customer controls all of the work-in-progress as products are being built. Revenues under these contracts are recognized progressively based on the cost-to-cost method. For other manufacturing contracts, the customer does not take control of the product until it is completed. Under these contracts, we recognize revenue upon transfer of control of the product to the customer, which is generally when the goods are shipped. Revenue from design, development and engineering services is recognized over time as the services are performed. As a general matter, we assume no significant obligations after shipment as we typically warrant workmanship only. Therefore, the warranty provisions are generally not significant.

COVID Pandemic Update

In late 2019, there was an outbreak of a new strain of coronavirus (COVID) first identified in Wuhan, Hubei Province, China, which has since spread globally. On March 11, 2020, the World Health Organization declared COVID a pandemic. Further, the COVID outbreak has resulted in government authorities around the world implementing numerous measures to try to reduce the spread of COVID, such as travel bans and restrictions, quarantines, “shelter-in-place,” “stay-at-home,” and total lock-down orders, business limitations or shutdowns and similar orders. As a result, the COVID pandemic has negatively impacted the global economy, disrupted global supply chains and workforce participation, and created significant volatility and disruption of financial markets. In an effort to first and foremost protect the health and safety of our employees, we took, and at times continue to take, proactive action to adopt social distancing policies at our locations globally. These measures include, but are not limited to, working from home for certain employees, limiting the number of employees attending meetings, reducing the number of people in our locations at any one time, and significantly limiting employee travel. More recently, more contagious variants of COVID, such as the Omicron variant and its subvariants, have emerged and spread globally, which initially caused many governments and businesses to reimplement various measures, or impose new restrictions, in an effort to lessen the spread of COVID and its variants. While many of these restrictions have been lifted, uncertainty remains as to whether additional restrictions may be initiated or again reimplemented in response to surges in COVID cases. The lingering impact of the COVID pandemic continues to create significant volatility throughout the global economy, including supply chain constraints, labor supply issues and higher inflation. Accordingly, it is unclear at this point the full impact COVID and its variants will have on the global economy and on our Company.

As a result of the COVID pandemic, our revenue during 2021 and the first nine months of 2022 has been negatively impacted primarily as a result of operational inefficiencies relating to reduced productivity levels throughout our facilities and supply chain constraints, which affected our ability to support customer demand. Additionally, the COVID pandemic negatively impacted our operating results due to increased direct costs associated with labor expenses and personal protective equipment for our employees.

Benchmark provides critical infrastructure products and essential services in each of our locations, which has allowed us to continue to operate. The COVID pandemic continues to affect the Company’s operations into 2022. End market demand continues to grow as more customers recover from the pandemic. However, we continue to see component supply chain constraints across all commodity categories which are constraining our ability to produce the full demand forecasts we are receiving from customers. See “Third Quarter 2022 Highlights” below for additional information.

On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) was enacted in the United States in response to the COVID pandemic. The CARES Act among other things, permits net operating loss carryovers and carrybacks to offset 100% of taxable income for taxable years beginning before 2021, and contains modifications on the limitation of business interest. The Company evaluated the impact of these provisions and determined these provisions did not have any impact on the nine months ended September 30, 2022. In addition, the CARES Act allows for employee retention tax credits to be taken in U.S. payroll tax filings and allows for the deferral of the employer portion of social security taxes with 50% to be paid at the end of calendar years 2021 and 2022, respectively. Accordingly, the Company deferred the payment of the employer portion of social security taxes for the year ended December 31, 2020 until the end of 2021 and 2022, respectively. During December 2021, the Company paid approximately 50% of the social security taxes previously deferred. The Company has also determined it was entitled to employee retention credits and filed for the credits in the second quarter 2020 payroll tax reports pursuant to the guidance provided by the Internal Revenue Service. The amount of credits has been recorded in operating expenses for the year ended December 31, 2020. The Company was not eligible for employee retention tax credits as of December 31, 2021. The Company has not received the retention credits from the Internal Revenue Service that it applied for during the second quarter of 2020. The Internal Revenue Service has had some delays in processing the filings for the tax refunds.

We continue to monitor the evolving situation and guidance from international and domestic authorities, including federal, state and local public health authorities, and may take additional actions based on their recommendations. In these circumstances, there may be developments outside our control requiring us to adjust our operating plan. As such, the exact extent of the impact of the COVID pandemic on our business, financial condition and results of operations, is currently unknown and will depend on future developments, which are highly uncertain, continuously evolving and cannot be predicted. This includes, but is not limited to, the duration and spread of the COVID pandemic and its severity; the emergence and severity of its variants, including the Omicron variant; the actions to contain the virus or treat its impact, including the availability and efficacy of vaccinations (particularly with respect to emerging strains of the virus) and the rate of inoculations; general economic factors, such as increased inflation; global supply chain constraints and shortages; labor supply issues; and how quickly and to what extent normal economic and operating conditions can resume, which may not return fully to pre-pandemic levels.

Accordingly, our current results and financial condition discussed herein may not be indicative of future operating results and trends. See “Risk Factors” in Part I, Item 1A of our 2021 10-K for additional risks we face due to the COVID pandemic.

Third Quarter 2022 Highlights

Sales for the three months ended September 30, 2022 were $771.6 million, a 35% increase from sales of $571.9 million during the three months ended September 30, 2021. During the third quarter of 2022, sales to customers in our various industry sectors fluctuated from the third quarter of 2021 as follows:

Higher-Value Markets

 Industrials increased by 44%,

 A&D decreased by 14%,

 Medical increased by 41%, and

 Semi-Cap increased by 39%.

Traditional Markets

 Computing increased by 67%, and

 Telecommunications increased by 52%.

The overall revenue increase was due primarily to higher overall demand from both our Higher-value and Traditional markets (as discussed below). Higher-value market revenues were up 29% year-over-year from strength in the Semi-Cap, Medical and Industrials sectors. Traditional market revenues were up 60% year-over-year from strength in both Computing and Telecommunications sectors.

Our sales depend on the success of our customers, some of which operate in businesses associated with rapid technological change and consequent product obsolescence. Developments adverse to our major customers or their products, the availability of electronic component supply, or the failure of a major customer to pay for components or services, including in each case as a result of the COVID pandemic, have adversely affected us. A substantial percentage of our sales are made to a small number of customers, and the loss of a major customer, if not replaced, would adversely affect us. Sales to our ten largest customers represented 53% and 47% of our total sales during the nine months ended September 30, 2022 and 2021, respectively. Due to the COVID pandemic, as well as global labor and supply disruptions, we continue to see component supply chain constraints across all commodity categories that are constraining our ability to produce the full demand forecasts we are receiving from customers. Lead times continue to extend, and more components are being placed on allocation by suppliers. Additionally, there continues to be an increase in pushouts of previously committed component orders and tighter allocation and timing restrictions across the component suppliers. Though we have recently started to see the easing of certain material constraints, these last-minute allocations created inefficiencies in our operations and contributed to the sequential increase in inventory, as well as increased costs to us and our customers.

We experience fluctuations in gross profit from period to period. Different programs contribute different gross profits depending on the type of services involved, location of production, size of the program, complexity of the product and level of material costs associated with the various products. Moreover, new programs can contribute relatively less to our gross profit in their early stages when manufacturing volumes are usually lower, resulting in inefficiencies and unabsorbed manufacturing overhead costs. During periods of low production volume, we generally have unabsorbed manufacturing overhead costs and reduced gross profit. Gross profit can also be impacted by higher costs associated with other situations, such as COVID and supply chain constraints. This includes supply chain premiums for excess component costs paid to secure available supply resulting in revenue with cost recovery only with no margin. In addition, a number of our new program ramps require incremental investment during the launch and ramp phase which can exert downward pressure on our gross profit.

We have undertaken initiatives to restructure our business operations with the intention of improving utilization and reducing costs. During the first nine months of 2022, we recognized $4.9 million of restructuring and other costs due to expenses associated with various site closures and restructuring activities, as well as a $2.0 million loss on assets held for sale related to the Company's 2021 decision to no longer continue certain manufacturing capabilities in the Americas and a gain on assets held for sale of $2.4 million related to the sale of our Angleton, Texas facility.

RESULTS OF OPERATIONS

The following table presents the percentage relationship that certain items in our condensed consolidated statements of income bear on sales for the periods indicated.

Three Months Ended September 30, 2022 2021 Nine Months Ended September 30, 2022 2021
Sales 100.0% 100.0% 100.0% 100.0%
Cost of sales 91.3 90.6 91.4 91.1
Gross profit 8.7 9.4 8.6 8.9
Selling, general and administrative expenses 5.0 6.0 5.2 6.1
Amortization of intangible assets 0.2 0.3 0.2 0.3
Restructuring charges and other costs 0.2 1.1 0.2 0.6
Ransomware related incident costs (recovery), net — (0.1) — (0.2)
Income from operations 3.3 2.1 3.0 2.1
Other expense, net (0.3) (0.3) (0.3) (0.3)
Income before income taxes 3.0 1.8 2.7 1.8
Income tax expense 0.6 0.4 0.5 0.4
Net income 2.4% 1.4% 2.2% 1.4%

Sales

As noted above, sales for the third quarter of 2022 increased 35% from the same quarter in 2021.

Sales are analyzed by management by industry sector and by geographic segment, which reflects our reportable segments. Our global business development strategy is based on our targeted industry sectors. Management measures operational performance and allocates resources on a geographic segment basis.

Sales by industry sector were as follows:

(in thousands)

Higher-Value Markets Three Months Ended September 30, 2022 2021 Nine Months Ended September 30, 2022 2021
Industrials $155,278 $108,192 $451,260 $303,550
A&D 86,238 100,838 257,322 286,899
Medical 165,546 117,793 448,653 334,888
Semi-Cap 186,325 133,576 544,661 385,890
593,387 460,399 1,701,896 1,311,227
Traditional Markets
Computing 94,562 56,557 218,254 139,841
Telecommunications 83,626 54,926 215,537 171,197
178,188 111,483 433,791 311,038
Total $771,575 $571,882 $2,135,687 $1,622,265

Industrials. Third quarter 2022 sales increased 44% to $155.3 million from $108.2 million in the third quarter of 2021. Sales during the first nine months of 2022 increased 49% to $451.3 million from $303.6 million in the same period of 2021. The increases were primarily due to continued demand improvements from energy-related products, building infrastructure, and light detection and ranging (LiDAR) applications.

Aerospace and Defense. Third quarter 2022 sales decreased 14% to $86.2 million from $100.8 million in the third quarter of 2021. Sales during the first nine months of 2022 decreased 10% to $257.3 million from $286.9 million in the same period of 2021. The decreases were primarily due to supply chain constraints with certain programs.

Medical. Third quarter 2022 sales increased 41% to $165.5 million from $117.8 million in the third quarter of 2021. Sales during the first nine months of 2022 increased 34% to $448.7 million from $334.9 million in the same period of 2021. The increases were primarily due to growth with existing customers and new program ramps.

Semiconductor Capital Equipment. Third quarter 2022 sales increased 39% to $186.3 million from $133.6 million in the third quarter of 2021. Sales during the first nine months of 2022 increased 41% to $544.7 million from $385.9 million in the same period of 2021. The increases were primarily due to high demand for our precision machining capabilities and complex system assembly.

Computing. Third quarter 2022 sales increased 67% to $94.6 million from $56.6 million in the third quarter of 2021. Sales during the first nine months of 2022 increased 56% to $218.3 million from $139.8 million in the same period of 2021. The increases were primarily due to the planned ramp of high-performance computing programs.

Telecommunications. Third quarter 2022 sales increased 52% to $83.6 million from $54.9 million in the third quarter of 2021. Sales during the first nine months of 2022 increased 26% to $215.5 million from $171.2 million in the same period of 2021. The increases were primarily due to continued demand strength and new ramps for broadband infrastructure.

Our international operations are subject to the risks of doing business abroad. See Part I, Item 1A of our 2021 10-K for factors pertaining to our international sales, fluctuations in foreign currency exchange rates and a discussion of potential adverse effects in operating results associated with the risks of doing business abroad. During the third quarter of 2022 and 2021, 61% and 54%, respectively, of our sales were from international operations.

Sales by geographic segment were as follows:

(in thousands)

Net sales: Three Months Ended September 30, 2022 2021 Nine Months Ended September 30, 2022 2021
Americas $400,905 $319,116 $1,066,760 $888,224
Asia 337,726 224,431 945,434 635,274
Europe 68,400 49,984 208,591 162,484
Elimination of intersegment sales: (35,456) (21,649) (85,098) (63,717)
Total net sales $771,575 $571,882 $2,135,687 $1,622,265

Americas. Third quarter 2022 sales increased 26% to $400.9 million from $319.1 million in the third quarter of 2021. Sales during the first nine months of 2022 increased 20% to $1,066.8 million from $888.2 million in the same period of 2021. The increases were primarily due to increasing demand with existing customers and new program ramps with existing and new customers.

Asia. Third quarter 2022 sales increased 50% to $337.7 million from $224.4 million in the third quarter of 2021. Sales during the first nine months of 2022 increased 49% to $945.4 million from $635.3 million in the same period of 2021. The increases were primarily due to increasing demand with existing customers, production ramps of new programs for existing customers and new customer program ramps.

Europe. Third quarter 2022 sales increased 37% to $68.4 million from $50.0 million in the third quarter of 2021. Sales during the first nine months of 2022 increased 28% to $208.6 million from $162.5 million in the same period of 2021. The increases were primarily due to increasing demand with existing customers and new customer program ramps.

Gross Profit

Gross profit increased 24% to $66.8 million in the third quarter of 2022 from $53.7 million in the third quarter of 2021. Gross profit increased 27.3% to $183.1 million in the first nine months of 2022 from $143.8 million in the same period of 2021. Gross margin decreased primarily due to the mix of our revenue, operational inefficiencies caused by supply chain challenges and the dilutive impact of revenue from supply chain premiums with no margin.

Operating Income

Third quarter 2022 operating income increased 114% to $25.3 million from $11.8 million in the third quarter of 2021. Operating income increased 83% to $63.1 million first nine months of 2022 from $34.4 million in the same period of 2021. The increases were primarily due to an increase in revenue and respective gross profit partially offset by an increase in selling, general and administrative (SG&A) expenses.

Operating income by reportable segment was as follows:

(in thousands)

Operating income: Three Months Ended September 30, 2022 2021 Nine Months Ended September 30, 2022 2021
Americas $14,608 $11,053 $41,094 $31,282
Asia 33,662 21,391 91,320 64,210
Europe 4,880 978 10,526 7,918
Corporate and other costs (27,866) (21,628) (79,817) (68,983)
Total operating income $25,284 $11,794 $63,123 $34,427

Americas. Third quarter 2022 operating income increased 32% to $14.6 million from $11.1 million in the third quarter of 2021. Operating income during the first nine months of 2022 increased 31% to $41.1 million from $31.3 million in the same period of 2021. The increases were primarily due to higher revenue.

Asia. Third quarter 2022 operating income increased 57% to $33.7 million from $21.4 million in the third quarter of 2021. Operating income during the first nine months of 2022 increased 42% to $91.3 million from $64.2 million in the same period of 2021. The increases were primarily due to higher revenue and improved productivity in labor.

Europe. Third quarter 2022 operating income increased 399% to $4.9 million from $1.0 million in the third quarter of 2021. Operating income during the first nine months of 2022 increased 33% to $10.5 million from $7.9 million in the same period of 2021. The increases were primarily due to higher revenue.

Selling, General and Administrative Expenses

SG&A increased to $38.5 million in the third quarter of 2022 from $34.4 million in the third quarter of 2021. SG&A increased to $110.7 million in the first nine months of 2022 from $99.0 million in the same period of 2021. The increases were primarily due to the increase in variable compensation and expenses related to continued IT infrastructure investments.

Amortization of Intangible Assets

Amortization of intangible assets was $1.6 million in both the third quarter of 2022 and 2021. Amortization of intangibles was $4.8 million in both the first nine months of 2022 and 2021.

Restructuring Charges and Other Costs

During the third quarter and first nine months of 2022, we recognized $1.3 million and $4.9 million of restructuring charges and other costs, respectively, primarily due to expenses associated with announced site closures or exits, reductions in force and other restructuring activities primarily in the Americas. During the first nine months of 2022, we also incurred a $2.0 million loss on assets held for sale related to certain manufacturing capabilities in the Americas that the Company made the decision in 2021 to no longer continue and a gain on assets held for sale of $2.4 million related to the sale of the Angleton, Texas facility. During the third quarter and first nine months of 2021, we recognized $2.0 million and $5.2 million of restructuring and other costs, respectively, primarily due to expenses associated with announced site closures or exits, reduction in force and other restructuring activities primarily in the Americas. Additionally, during the third quarter of 2021, the Company made the decision to no longer continue certain manufacturing capabilities in the Americas. In connection with that decision, the Company assessed the facility and equipment assets used in those manufacturing capabilities using valuation information from third parties and recorded $4.4 million of impairment charges as a result of that assessment. See Note 12 to the condensed consolidated financial statements in Part I, Item 1 of this Report for additional information on our restructuring charges.

Ransomware Incident Related Costs, Net

No insurance recoveries were made in the third quarter or first nine months of 2022. Insurance recoveries of $0.5 million and $3.9 million were collected during the third quarter of 2021 and first nine months of 2021, respectively. As of September 30, 2022, no further insurance recoveries are expected.

Interest Expense

Interest expense increased to $3.5 million in the third quarter of 2022 from $2.0 million in the third quarter of 2021. Interest expense increased to $7.4 million in the first nine months of 2022 from $6.2 million in the same period of 2021. The increases were primarily due to increased borrowings under our revolving credit facility to support investment in working capital.

Interest Income

Interest income increased to $0.5 million in the third quarter of 2022 from $0.1 million in the third quarter of 2021. Interest income increased to $0.8 million in the first nine months of 2022 from $0.5 million in the same period of 2021. The increases were primarily due to higher interest rates.

Income Tax Expense

Income tax expense of $4.5 million represented a 19.3% effective tax rate for the third quarter of 2022, compared with $2.4 million in the third quarter of 2021 representing an effective tax rate of 19.1%. Income tax expense of $11.1 million represented a 19.1% effective tax rate for the first nine months of 2022, compared with $6.0 million for the same period of 2021 representing an effective tax rate of 20.1%. The differences between the effective tax rates for 2022 compared to 2021 is related to the mix of profits in our various jurisdictions.

We have been granted certain tax incentives, including tax holidays, for our subsidiaries in China and Thailand that will expire at various dates, unless extended or otherwise renegotiated, through 2023 in China and 2030 in Thailand. See Note 8 to the condensed consolidated financial statements in Part I, Item 1 of this Report.

Net Income

We reported a net income of $18.8 million, or $0.53 per diluted share, for the third quarter of 2022, compared with a net income of $8.1 million, or $0.23 per diluted share, for the third quarter of 2021. We reported a net income of $47.0 million, or $1.32 per diluted share, for the first nine months of 2022, compared with a net income of $23.4 million, or $0.64 per diluted share, for the same period in 2021. The increases were primarily the result of items discussed above.

LIQUIDITY AND CAPITAL RESOURCES

We have historically financed our organic growth and operations through funds generated from operations and borrowings under our Credit Agreement (as defined below). Cash and cash equivalents and restricted cash totaled $249.3 million at September 30, 2022 and $271.7 million at December 31, 2021, of which $189.6 million and $194.7 million, respectively, were held outside the U.S. in various foreign subsidiaries.

Cash used in operating activities was $124.7 million during the first nine months of 2022. The cash used in operations during 2022 consisted primarily of a $228.5 million increase in inventories, a $123.6 million increase in accounts receivable, a $32.5 million increase in contract assets, a $9.8 million increase in prepaids and other assets and a $2.0 decrease in accrued liabilities, partially offset by $47.0 million of net income, $33.0 million of depreciation and amortization, a $93.5 million increase in advance payments from customers and a $84.6 million increase in accounts payable. Working capital was $0.9 billion at September 30, 2022 and $0.7 billion at December 31, 2021. The growth in working capital is a result of the proactive investment in inventory to support our revenue growth.

We primarily purchase components only after customer orders or forecasts are received, which mitigates, but does not eliminate, the risk of loss on inventories. Supplies of electronic components and other materials used in operations are subject to industry-wide shortages. In certain instances, suppliers may allocate available quantities to us. When shortages of these components and other material supplies used in operations have occurred, vendors have at times been unable to ship the quantities we need for production, forcing us to delay shipments, which can increase backorders and impact cash flows. Vendors also may increase the costs of components based on the market conditions including these shortages. In certain instances, we request and receive advance payments from customers as prepayments of inventory to meet working capital demands of a contract, offset inventory risks such as inventory purchased in advance of current needs and protect the Company from the failure of other parties to fulfill obligations under a contract. For example, as discussed above under “COVID Pandemic Update,” we have been impacted by supply chain constraints, including shortages, longer lead times and increased transit times.

Cash used in investing activities was $27.9 million during the first nine months of 2022 primarily due to purchases of additional property, plant and equipment totaling $30.2 million and purchased software of $3.4 million, partially offset by proceeds from the sale of assets held for sale of $5.4 million. The purchases of property, plant and equipment were primarily for machinery and equipment in the Americas.

Cash provided by financing activities was $139.8 million during the first nine months of 2022. Borrowings under the Credit Agreement were $593.0 million and proceeds from stock option exercises were $0.5 million. Principal payments under the Credit Agreement totaled $423.0 million, dividends paid totaled $17.4 million, share repurchases totaled $9.4 million and debt issuance costs totaled $0.6 million.

On December 21, 2021, the Company amended and restated the Company's prior $650 million credit agreement by entering into a $381 million amended and restated credit agreement (the Amended and Restated Credit Agreement). Under the terms of the Amended and Restated Credit Agreement, in addition to the $131.3 million term loan facility, we have a $250.0 million five-year revolving credit facility to be used for general corporate purposes, both with a maturity date of December 21, 2026. On May 20, 2022, the Company entered into Amendment No. 1 (the Amendment) to the Amended and Restated Credit Agreement (as amended, the Credit Agreement). The Amendment, among other things, increased the revolving credit facility commitments from $250 million to $450 million. The Credit Agreement includes an accordion feature pursuant to which the Company is permitted to add one or more incremental term loans and/or increase commitments under the revolving credit facility in an aggregate amount of $100 million or a higher amount, subject to the satisfaction of certain conditions and exceptions. As of September 30, 2022, we had $131.3 million in borrowings outstanding under the term loan facility, $170.0 million in borrowings outstanding under the revolving credit facility, and $3.9 million in letters of credit outstanding under our revolving credit facility. Under the revolving credit facility, $276.1 million remains available for future borrowings, subject to compliance with financial covenants as to interest coverage and debt leverage, in addition to other debt covenant restrictions. See Note 5 to the condensed consolidated financial statements in Part I, Item 1 of this Report for more information regarding the terms of the Credit Agreement.

The Credit Agreement contains certain financial covenants related to interest coverage and debt leverage, and certain customary affirmative and negative covenants, including restrictions on our ability to incur additional debt and liens, pay dividends, repurchase shares, sell assets and merge or consolidate with other persons. Amounts due under the Credit Agreement could be accelerated upon specified events of default, including a failure to pay amounts due, breach of a covenant, material inaccuracy of a representation, or occurrence of bankruptcy or insolvency, subject, in some cases, to cure periods. As of September 30, 2022, we were in compliance with all of these covenants and restrictions.

Our operations, and the operations of businesses we acquire, are subject to certain foreign, federal, state and local regulatory requirements relating to environmental, waste management, health and safety matters. We believe we operate in substantial compliance with all applicable requirements and we seek to ensure that newly acquired businesses comply or will comply substantially with applicable requirements. To date, the costs of compliance and workplace and environmental remediation have not been material to us. However, material costs and liabilities may arise from these requirements or from new, modified or more stringent requirements in the future. In addition, our past, current and future operations, and the operations of businesses we have or may acquire, may give rise to claims of exposure by employees or the public, or to other claims or liabilities relating to environmental, waste management or health and safety concerns.

As of September 30, 2022, we had cash and cash equivalents, including restricted cash, totaling $249.3 million and $276.1 million available for borrowings under the Credit Agreement, subject to compliance with financial covenants as to interest coverage and debt leverage, in addition to other debt covenant restrictions.

During the next 12 months, we believe our capital expenditures will approximate $50 million to $60 million, principally for machinery and equipment to help increase our production capacity to support anticipated revenue growth and our ongoing business around the globe.

On March 6, 2018, our Board of Directors approved an expanded stock repurchase program granting us the authority to repurchase up to $250 million in common stock in addition to the $100 million approved on December 7, 2015. On February 19, 2020 and October 26, 2021, the Board of Directors authorized the repurchase of an additional $150 million and $100 million, respectively, of shares of the Company's common stock. During the nine months ended September 30, 2022, we repurchased a total of 0.4 million common shares for an aggregate of $9.4 million at an average price of $24.96 per share. As of September 30, 2022, we had $154.6 million remaining under the share repurchase authorization to purchase additional shares. We are under no commitment or obligation to repurchase any particular amount of common stock.

The Company began declaring and paying quarterly dividends during the first quarter of 2018. In February 2020, the Board of Directors approved a quarterly dividend increase, raising the quarterly dividend from $0.15 to $0.16 per common share. In May 2021, the Board of Directors approved another quarterly dividend increase, raising the quarterly dividend from $0.16 to $0.165 per common share. During both the first nine months of 2022 and 2021, cash dividends paid totaled $17.4 million. On September 12, 2022, the Company declared a quarterly cash dividend of $0.165 per share of the Company’s common stock to shareholders of record as of September 30, 2022. The dividend of $5.8 million was paid on October 14, 2022. The Board of Directors currently intends to continue paying quarterly dividends. However, the Company’s future dividend policy is subject to the Company’s compliance with applicable law, and depends on, among other things, the Company’s results of operations, financial condition, level of indebtedness, capital requirements, contractual restrictions, restrictions in the Company’s debt agreements, and other factors that the Board of Directors may deem relevant, including the impact of the COVID pandemic. Dividend payments are not mandatory or guaranteed; there can be no assurance that the Company will continue to pay a dividend in the future.

Management believes that our existing cash balances, funds generated from operations, and borrowing availability under our revolving credit facility will be sufficient to permit us to meet our liquidity requirements over the next 12 months. Management further believes that our ongoing cash flows from operations and any borrowings we may incur under our revolving credit facility will enable us to meet operating cash requirements in future years. If we consummated significant acquisitions in the future, our capital needs would increase and could possibly result in our need to increase available borrowings under our Credit Agreement or access public or private debt and equity markets. There can be no assurance, however, that we would be successful in raising additional debt or equity on acceptable terms.

CONTRACTUAL OBLIGATIONS

We have certain contractual obligations for operating and capital leases that were summarized in Contractual Obligations in our 2021 10-K. Other than items discussed in Note 6 to the condensed consolidated financial statements in Part I, Item 1 of this Report, there have been no material changes to our contractual obligations, outside of the ordinary course of our business, since December 31, 2021.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES AND RECENTLY ENACTED ACCOUNTING PRINCIPLES

Management’s discussion and analysis is based upon our condensed consolidated financial statements, which have been prepared in accordance with U.S. GAAP. See Note 2 to the condensed consolidated financial statements in Part I, Item 1 of this Report for a discussion of recently enacted accounting principles. Also, our significant accounting policies are summarized in Note 1 to the Consolidated Financial Statements included in our 2021 10-K. There have been no changes to the items disclosed as critical accounting estimates in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Part II, Item 7 of our 2021 10-K.

Market risk

As filed, 3,225 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Our international sales comprise a significant portion of our net sales. We are exposed to risks associated with operating internationally, including:

  • Foreign currency exchange risk;
  • Import and export duties, taxes and regulatory changes;
  • Inflationary economies or currencies; and
  • Economic and political instability.

Additionally, some of our operations are in developing countries. Certain events, including natural disasters, can impact the infrastructure of a developing country more severely than they would impact the infrastructure of a developed country. A developing country can also take longer to recover from such events, which could lead to delays in our ability to resume full operations.

We transact business in various foreign countries and are subject to foreign currency fluctuation risks. We use natural hedging and forward contracts to economically hedge transactional exposure primarily associated with trade accounts receivable, other receivables, trade accounts payable, and lease liabilities that are denominated in a currency other than the functional currency of the respective operating entity. We do not use derivative financial instruments for speculative purposes. Certain forward currency exchange contracts in place as of September 30, 2022 have not been designated as accounting hedges and, therefore, changes in fair value are recorded within our condensed consolidated statements of income.

On July 30, 2021, the Company entered into forward currency exchange contracts designated as cash flow hedges of forecasted foreign currency expenses. Changes in the fair value of the derivatives are recorded in accumulated other comprehensive loss in the condensed consolidated balance sheets until earnings are affected by the variability of the cash flows.

Our sales are substantially denominated in U.S. dollars. Our foreign currency cash flows are generated in certain European and Asian countries and Mexico.

We are also exposed to market risk for changes in interest rates on our financial instruments, a portion of which relates to our invested cash balances. We do not use derivative financial instruments in our investing activities. We place cash and cash equivalents and investments with various major financial institutions. We protect our invested principal funds by limiting default risk, market risk and reinvestment risk. We mitigate default risk by generally investing in investment-grade securities.

We are also exposed to interest rate risk on borrowings under our Credit Agreement. As of September 30, 2022, we had $131.3 million outstanding on the floating rate term loan facility, and we have an interest rate swap agreement with a notional amount of $123.8 million. Under this swap agreement, we receive variable rate interest rate payments and pay fixed rate interest payments. The effect of this swap is to convert a portion our floating rate interest expense to fixed interest rate expense. The interest rate swap is designated as a cash flow hedge.

For additional information regarding our forward currency exchange contracts and interest rate swap agreement, see Note 15 to the condensed consolidated financial statements in Part I, Item 1 of this Report.

Controls and procedures

As filed, 3,341 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

As of the end of the period covered by this Report, the Company’s management (with the participation of our Chief Executive Officer (CEO) and Chief Financial Officer (CFO)) conducted an evaluation pursuant to Rule 13a-15 under the Exchange Act of the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rule 13a-15(e) or 15d-15(e) of the Exchange Act). Based on this evaluation, the CEO and CFO concluded that as of the end of the period covered by this Report, such disclosure controls and procedures were effective at a reasonable assurance level to ensure that information required to be disclosed by the Company in reports it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC and that such information is accumulated and communicated to the Company’s management, including the CEO and CFO, as appropriate to allow timely decisions regarding required disclosure.

There has been no change in the Company’s internal control over financial reporting (as defined in Rule 13a-15(f) or 15d-15(f) of the Exchange Act) that occurred during the last fiscal quarter covered by this Report that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

We are currently upgrading our enterprise resource planning (ERP) system, which is expected to occur in phases over the next several years. We have completed the implementation of the upgrades at certain of the Company’s locations, and have revised and updated the related controls. These changes did not materially affect our internal control over financial reporting. As we implement the upgrades of this ERP system at the remaining locations over the next several years, we will continue to assess the impact on our internal control over financial reporting.

A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple errors or mistakes. Additionally, controls can be circumvented by individuals’ acts, by collusion of two or more people, or by management overriding the control. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, a control may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2022-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2022-07-01 to 2022-09-30$807.0mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue9 months2022-01-01 to 2022-09-30$2.22bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2022-07-01 to 2022-09-30$704.8mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue9 months2022-01-01 to 2022-09-30$1.95bnus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2022-07-01 to 2022-09-30$66.8mus-gaap:GrossProfit
Gross profit9 months2022-01-01 to 2022-09-30$183.1mus-gaap:GrossProfit
Selling, general and administrative3 months2022-07-01 to 2022-09-30$38.5mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2022-01-01 to 2022-09-30$110.7mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2022-07-01 to 2022-09-30$25.3mus-gaap:OperatingIncomeLoss
Operating income9 months2022-01-01 to 2022-09-30$63.1mus-gaap:OperatingIncomeLoss
Interest expense3 months2022-07-01 to 2022-09-30$3.5mus-gaap:InterestExpense
Interest expense9 months2022-01-01 to 2022-09-30$7.4mus-gaap:InterestExpense
Income tax3 months2022-07-01 to 2022-09-30$4.5mus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2022-01-01 to 2022-09-30$11.1mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2022-07-01 to 2022-09-30$18.8mus-gaap:NetIncomeLoss
Net income9 months2022-01-01 to 2022-09-30$47.0mus-gaap:NetIncomeLoss
Diluted EPS3 months2022-07-01 to 2022-09-30$0.53us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2022-01-01 to 2022-09-30$1.32us-gaap:EarningsPerShareDiluted
Basic EPS3 months2022-07-01 to 2022-09-30$0.54us-gaap:EarningsPerShareBasic
Basic EPS9 months2022-01-01 to 2022-09-30$1.34us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2022-07-01 to 2022-09-3035,348,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2022-01-01 to 2022-09-3035,604,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2022-01-01 to 2022-09-30−$124.7mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2022-07-01 to 2022-09-30$8.6mus-gaap:PaymentsToAcquireProductiveAssets
Capital expenditure9 months2022-01-01 to 2022-09-30$30.2mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid9 months2022-01-01 to 2022-09-30$17.4mus-gaap:PaymentsOfDividends
Share repurchases9 months2022-01-01 to 2022-09-30$9.4mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2022-09-30$247.3mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2022-09-30$1.71bnus-gaap:AssetsCurrent
Total assetsAt period end2022-09-30$2.28bnus-gaap:Assets
Current liabilitiesAt period end2022-09-30$848.9mus-gaap:LiabilitiesCurrent
Long-term debtAt period end2022-09-30$299.3mus-gaap:LongTermDebt
Shareholders' equityAt period end2022-09-30$1.00bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000950170-22-022201. Last ingested by Listed: Oct 24, 2026, 14:58 ET. Listed shows no prices and gives no investment advice.